ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,146Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 1006

$817K Total Retail Price of All Prescriptions

Rank: 75 out of 1006

422 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 422 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 422 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,777 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 468 405 1 1
LISINOPRIL 435 382 2 3
FUROSEMIDE 394 376 3 6
AMLODIPINE BESYLATE 284 238 4 4
WARFARIN SODIUM 274 256 5 8
DONEPEZIL HCL 273 259 6 17
METOPROLOL TARTRATE 272 220 7 7
LEVOTHYROXINE SODIUM 261 259 8 2
ATORVASTATIN CALCIUM 239 233 9 5
SERTRALINE HCL 207 187 10 19
ATENOLOL 202 202 11 13
CYMBALTA 183 158 12 41
AZITHROMYCIN 178 154 13 39
METOPROLOL SUCCINATE 173 151 14 12
TRAZODONE HCL 171 162 15 21
MIRTAZAPINE 171 171 15 26
NAMENDA 159 159 17 34
HYDROCHLOROTHIAZIDE 152 115 18 11
OMEPRAZOLE 148 140 19 9
ESCITALOPRAM OXALATE 139 98 20 27
FENTANYL 117 101 S2 21 74
NEXIUM 114 86 22 28
ZETIA 113 84 23 51
OLANZAPINE 108 108 24 68
DIOVAN 107 105 25 16
OXYCODONE-ACETAMINOPHEN 104 97 S2 26 57
HYDROCODONE-ACETAMINOPHEN 101 77 S3 27 25
SPIRIVA 97 71 28 48
GABAPENTIN 96 82 29 20
ADVAIR DISKUS 90 77 30 37
ALLOPURINOL 89 85 31 31
POTASSIUM CHLORIDE 85 84 32 30
METFORMIN HCL 80 65 33 10
FLUTICASONE PROPIONATE 77 64 34 55
LOSARTAN POTASSIUM 76 74 35 22
ZOLPIDEM TARTRATE 75 71 36 14
DIGOXIN 74 67 37 52
KLOR-CON M20 73 73 38 70
TAMSULOSIN HCL 70 59 39 23
AMOX TR-POTASSIUM CLAVULANATE 68 59 40 123
DIVALPROEX SODIUM 68 65 40 53
MELOXICAM 67 62 42 67
CLOPIDOGREL 66 66 43 46
PLAVIX 64 64 44 61
PANTOPRAZOLE SODIUM 60 59 45 32
CIPROFLOXACIN HCL 59 54 46 75
LOVASTATIN 59 55 46 44
OXYBUTYNIN CHLORIDE ER 56 43 48 92
LIDODERM 54 54 49 66
LEVOFLOXACIN 53 46 50 96
TRANSDERM-SCOP 52 52 51 227
CRESTOR 50 29 52 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.